ArticleHealth economics review2021
Investing preventive care and economic development in ageing societies: empirical evidences from OECD countries.
Article in Health economics review, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Robustness in Older Adults: A Concept Analysis Using Rodgers' Evolutionary Approach.Nursing & health sciences · 2026Review
- Preventable mortality in Mexico: bridging gaps in chronic disease and ageing care.BMJ global health · 2026Review
- Social impact bonds: opportunities for funding health promotion and disease prevention.BMC public health · 2026Article
- Research on the path of high-quality development of the smart health and aging care industry driven by digital economy- dynamic QCA analysis based on TOE framework.Frontiers in public health · 2026Article
- Psychological and socio-contextual factors influencing preventive healthcare decision-making: evidence from IT and ITES companies in three cities of India.BMC health services research · 2025Article
- Structured Clinical Tools for Periodic Health Assessment of Older Adults in Primary Care: A Scoping Review.Health science reports · 2025Review
- Multi-target synergistic anti-aging: QG extends Caenorhabditis elegans lifespan through DAF-16/FOXO pathways, mitochondrial homeostasis and metabolic reprogramming.Biogerontology · 2025Article
- The burden of inflammatory bowel disease in five East Asian countries an analysis based on the global burden of disease study 1990-2021.BMC gastroenterology · 2025Article
- Barriers and facilitators of preventive healthcare access among immigrants in rural America: a scoping review.International journal for equity in health · 2025Article
- Reduction of DNA Topoisomerase Top2 Reprograms the Epigenetic Landscape and Extends Health and Life Span Across Species.Aging cell · 2025Article
- Participation in Healthy Ageing Centres in Bosnia and Herzegovina Is Associated with Increased Physical Activity, Social Interactions, and Life Satisfaction Among Older People: A Cross-Sectional Study.Journal of ageing and longevity · 2025Article
- Grand challenge: addressing the global challenge of healthy aging.Frontiers in public health · 2025Article
- Forecast of total health expenditure on China's ageing population: a system dynamics model.BMC health services research · 2024Article
- Comparison of atherosclerotic cardiovascular disease (ASCVD) and Framingham risk scores (FRS) in an Iranian population.International journal of cardiology. Cardiovascular risk and prevention · 2024Article
- Determinants of private-sector antibiotic consumption in India: findings from a quasi-experimental fixed-effects regression analysis using cross-sectional time-series data, 2011-2019.Scientific reports · 2024Article
- Estimation of lifetime productivity loss from patients with chronic diseases: methods and empirical evidence of end-stage kidney disease from Taiwan.Health economics review · 2024Article
- Services as a Determinant of Botswana's Economic Sustainability.International journal of environmental research and public health · 2022Article
- Noncommunicable Diseases Prevention and Cure: Work Performance and Gender Disparities in Mortality Risk.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe proportion of the elderly aged 65 years old or above will reach 16% in 2050 worldwide. Early investment in effective prevention would generally reduce the morbidity, complication, functional disability, and mortality of most chronic illnesses and save resources in both healthcare and social services. This research aims to investigate how the optimal allocation of medical resources between prevention and treatment adds value to the population's health as well as examine the interaction between ageing, health, and economic performance.
methodsThis research undertakes ageing-health analyses by developing an economic growth model. Based on the Organization for Economic Co-Operation and Development (OECD) countries' experiences over the period from 2000 to 2017, this research further examines the hypothesis that an ageing society could increase demand for preventive and curative healthcare.
resultsTheoretical analysis found that the prevention share for maximizing growth is the same as that for minimizing ill health and maximizing welfare; this share increases with treatment share and ageing ratios. Estimation results from OECD countries' experiences indicate that when treatment share increases by 1%, the prevention demand increases by 0.036%. A one-percent increase in the ageing ratio yields a change in prevention share of 0.0368%. The optimal share of prevention health expenditure to GDP would be 1.175% when the prevalence rate of ill health isat 6.13%; a higher or lower share of prevention would be accompanied with a higher prevalence of ill health. For example, a zero and 1.358% preventive health expenditure would be associated with an 18.01% prevalence of ill health, while the current share of prevention of 0.237% is associated with a 10.26% prevalence of ill health.
conclusionThis study shows that appropriate prevention is associated with decreases in the prevalence rates of ill health, which in turn attains sustainable growth in productivity. Too much prevention, however, could lead to higher detection of new chronic diseases with mild severity, which would result in longer illness duration, and higher prevalence rates of ill health. With suitable allocation of medical resources, the economic growth rate will help to cancel out increases in healthcare spending for the elderly and for expenses needed for the improvement of the population's health as a whole.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.